Position in TLRY
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$62,377
-$26,920 QoQ
Shares Held
9,641
-2.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $1,164,451,125 across 44 Drug Manufacturers - Specialty & Generic names. TLRY ranks #42 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,532,028 | $653,941,023 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
198,777 | $117,870,782 | |
| 3 | VTRS |
Viatris Inc
|
6,512,440 | $87,983,060 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,829,970 | $85,238,695 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
365,345 | $48,130,546 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
523,691 | $25,215,720 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
319,675 | $24,583,006 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
236,885 | $17,967,724 |
All Filings in TLRY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $62,377 | 9,641 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $89,297 | 9,889 | Shares | Defined | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||